HopeStage
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
More filters: keywords, city, remote
2276studies shown
Showing 49-60 of 2,276
Drug study icon
RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In Australia
DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, Australia, Canada, ...
Sponsor
Eli Lilly and Company
Condition
Depression
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

In Australia
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

Location not clearly listed
SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Australia, Canada, ...
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
Drug study icon
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in New Zealand, ...

In Australia
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, New Zealand, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT07424404

Xanomeline and Trospium Chloride for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

Location not clearly listed
SchizophreniaDrugFrom 5 Years to 17 Years
Countries
United States, Australia, France, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT07196501

Maintenance Effect of Osavampator for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In Australia
DepressionDrugOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingACTRN12618001956291

A study to investigate the Safety and Tolerability of AB-2004 in a Pediatric Autism Spectrum Disorder Population

The registry describes this research topic: “A study to investigate the Safety and Tolerability of AB-2004 in a Pediatric Autism Spectrum Disorder Population”. This is an interventional study.

In Australia
Mental healthDrugFrom 12 Years to 17 Years
Countries
Australia, New Zealand
Sponsor
Axial Biotherapeutics Australia Pty Ltd.
Condition
Mental health
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.